Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.37 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.35 |
| ▸ | KDM1A | O60341 | 2/20 | 0.33 |
| ▸ | CRHBP | P24387 | 2/20 | 0.33 |
| ▸ | CRHR2 | Q13324 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | C1R | P00736 | 1/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.31 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.30 |
| ▸ | GSK3B | P49841 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.30 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13060321 | 1.00 | ABCG2 (0.37) | ABCG2PTGDR2KDM1ACRHBPCRHR2 | |
| SCHEMBL13060319 | 1.00 | ABCG2 (0.37) | ABCG2PTGDR2KDM1ACRHBPCRHR2 | |
| SCHEMBL13060258 | 1.00 | ABCG2 (0.37) | ABCG2PTGDR2KDM1ACRHBPCRHR2 | |
| SCHEMBL13060302 | 0.95 | ABCG2 (0.32) | ABCG2 | |
| SCHEMBL13060292 | 0.95 | ABCG2 (0.32) | ABCG2 | |
| SCHEMBL13060308 | 0.93 | ALDH1A1 (0.33) | ABCG2MAPTTSHR | |
| SCHEMBL13060303 | 0.92 | ABCG2 (0.35) | ABCG2PTGDR2KDM1ACRHBPCRHR2 | |
| SCHEMBL24236403 | 0.91 | ABCG2 (0.36) | ABCG2PTGDR2KDM1ACRHBPCRHR2 | |
| SCHEMBL13060310 | 0.91 | ABCG2 (0.34) | ABCG2PTGDR2KDM1ACRHBPCRHR2 | |
| SCHEMBL13060511 | 0.91 | ABCG2 (0.34) | ABCG2PTGDR2KDM1ACRHBPCRHR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7846558-B2 | Blue light emitting compound and organic electroluminescent device using the same | SFC CO., LTD. (KR) | 2010-12-07 | — | — | US | disclosed |
| US-20080203905-A1 | Blue light emitting compound and organic electroluminescent device using the same | SFC CO., LTD. (KR) | 2008-08-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080203905-A1 | Blue light emitting compound and organic electroluminescent device using the same | TYR, CYBA, CRY2 | ABCG2 2182/4885PTGDR2 3961/4885KDM1A 1215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.